Eli Lilly & Company has recalled 36,540 vials of Zyprexa (olanzapine) for Injection, 10 mg, due to quality deviations. The medication, which is a dried powder (lyophilized cake) intended to be mixed with liquid for injection, may show an atypical appearance, including a decrease in size and a change in color. These physical changes indicate the product may not have been manufactured or stored according to strict quality standards, which could affect how the medication dissolves or its potency. Consumers should contact their healthcare provider or pharmacist immediately if they possess this medication.
The deviation in the physical appearance and size of the drug cake suggests a potential loss of stability or improper manufacturing conditions, which could lead to unpredictable drug performance or reduced efficacy for patients requiring this antipsychotic medication.
Healthcare provider consultation and pharmacy return.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.